Intrinsiqq
BridgeBio Oncology Therapeutics, Inc. logo

BridgeBio Oncology Therapeutics, Inc. Intrinsic Value

BBOT

Compare

BridgeBio Oncology Therapeutics fair value

None of the figures this calculator works from (earnings, free cash flow, revenue, book value, dividends) is positive for BridgeBio Oncology Therapeutics today, so there is nothing to project yet.

Peers

Pharmaceutical Preparations · Pick stocks to compare with BBOT

CompareIntrinsic value
GANXGain Therapeutics Inc.
$1.00-4.86%25
KURAKura Oncology Inc.
$6.91-5.99%10
IRDOpus Genetics Inc.
$3.99-2.21%10
PVCTProvectus Biopharmaceuticals, Inc.
$0.05+1.11%6
VSTMVerastem Inc.
$6.33-7.73%40
LXRXLexicon Pharmaceuticals, Inc.
$1.53-8.38%40
COLLCollegium Pharmaceutical Inc.
$24.72-1.94%85
SVRASavara Inc.
$4.26-18.23%10

Held by ETFs

BBOT is in 7 US ETFs. The largest of them, with BBOT's weight in each:

Spot a number that looks wrong? Check it in BBOT's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing BBOT

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.